当前位置: 首页 >> 检索结果
共有 87562 条符合本次的查询结果, 用时 4.4034428 秒

481. Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

作者: Roger A Fleischman.
来源: N Engl J Med. 2025年393卷22期2279页

482. Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Reply.

作者: Julio Rosenstock.;David Cox.;Max Denning.
来源: N Engl J Med. 2025年393卷22期2277-2279页

483. Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes.

作者: Xuemei Xie.;Xiuping Xuan.
来源: N Engl J Med. 2025年393卷22期2276-2277页

484. Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes.

作者: Siva P Jagarlapudi.
来源: N Engl J Med. 2025年393卷22期2276页

485. Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes.

作者: Tadasu Nagaoka.
来源: N Engl J Med. 2025年393卷22期2276页

486. Once-Monthly Maridebart Cafraglutide in Obesity - A Phase 2 Trial. Reply.

作者: Ania M Jastreboff.;Donna H Ryan.;Nicola Pannacciulli.
来源: N Engl J Med. 2025年393卷22期2275页

487. Once-Monthly Maridebart Cafraglutide in Obesity - A Phase 2 Trial.

作者: Marcel H A Muskiet.;Mark M Smits.
来源: N Engl J Med. 2025年393卷22期2274-2275页

488. Once-Monthly Maridebart Cafraglutide in Obesity - A Phase 2 Trial.

作者: Qiyuan K Liu.
来源: N Engl J Med. 2025年393卷22期2274页

489. Stability of Avian Influenza A(H5N1) Virus in Milk from Infected Cows and Virus-Spiked Milk.

作者: Lizheng Guan.;David Pattinson.;Amie J Eisfeld.;Tong Wang.;Peter J Halfmann.;Gabriele Neumann.;Tera R Barnhardt.;Alexis C Thompson.;Amy K Swinford.;Kiril M Dimitrov.;Keith Poulsen.;Yoshihiro Kawaoka.
来源: N Engl J Med. 2025年393卷22期2271-2273页

490. Simplify or Stratify? The Debate over Medical School Grading Systems.

作者: Harleen Marwah.;Abhinav Suri.;Clarence H Braddock.;Dawn E DeWitt.;Rhett Oellrich.
来源: N Engl J Med. 2025年393卷22期2268-2270页

491. Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN.

作者: Ladan Zand.;Fernando C Fervenza.
来源: N Engl J Med. 2025年393卷22期2266-2267页

492. Clouded by Smoke.

作者: Derek R Soled.;Manuela Cernadas.;Arezou A Ghazani.;Katherine H Walker.;Bruce D Levy.
来源: N Engl J Med. 2025年393卷22期2255-2261页

493. Empyema Necessitans.

作者: Adeoluwa Ayoola.;Kreshnik Zejnullahu.
来源: N Engl J Med. 2025年393卷22期e38页

494. Idiopathic Normal-Pressure Hydrocephalus.

作者: Mark D Johnson.;Michael A Williams.
来源: N Engl J Med. 2025年393卷22期2243-2253页

495. Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

作者: Fadi Fakhouri.;Andrew S Bomback.;Gema Ariceta.;Yahsou Delmas.;Bradley P Dixon.;Daniel P Gale.;Larry A Greenbaum.;Seung Hyeok Han.;Nicole Isbel.;Moglie Le Quintrec.;Christoph Licht.;Antonio Mastrangelo.;Masashi Mizuno.;Maria Izabel Neves de Holanda.;Matthew C Pickering.;Giuseppe Remuzzi.;Nicole Van De Kar.;Marina Vivarelli.;Patrick D Walker.;Dean Wallace.;Daniel Zecher.;Cedric Francois.;Pascal Deschatelets.;Li Li.;Zhongshen Wang.;Lydia Abad-Franch.;Nils Kinnman.;Luis López-Lázaro.;Johan Szamosi.;Carla M Nester.; .
来源: N Engl J Med. 2025年393卷22期2210-2220页
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of pegcetacoplan, a C3 and C3b inhibitor, in persons with C3 glomerulopathy or primary immune-complex MPGN are unclear.

496. Complete Heart Block Detected by Consumer-Facing Digital Health Technologies.

作者: James E Ip.
来源: N Engl J Med. 2025年393卷22期2254页

497. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy.

作者: David M Cutler.;Robert S Huckman.
来源: N Engl J Med. 2025年393卷22期2177-2180页

498. The New U.S. Global Health Strategy - A Reset of America's Health Cooperation.

作者: Jirair Ratevosian.;Chris Beyrer.;Mumbi Chola.;Megan Huchko.;Shingai Machingaidze.;Krishna Udayakumar.;Gavin Yamey.
来源: N Engl J Med. 2025年393卷22期2180-2182页

499. From Bandwidth to Bedside - Bringing AI-Enabled Care to Rural America.

作者: Angelo E Volandes.;Aretha D Davis.;Nathan E Goldstein.
来源: N Engl J Med. 2025年393卷22期2182-2185页

500. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. Reply.

作者: Peter D Friedmann.;Elizabeth A Evans.
来源: N Engl J Med. 2025年393卷21期2176页
共有 87562 条符合本次的查询结果, 用时 4.4034428 秒